 Alzheimer's disease has also been associated with reduced human PNMT activity in the regions of the brain most associated with degeneration in the disease.There have also been significant associations with PNMT polymorphisms and early onset Alzheimer's disease.Classic PNMT inhibitors include benzimidazoles, quinolones, and purines.